Morimoto-Pharma Group(MPG) was founded in 2005 by Shuji Morimoto who was the research manager of Takeda Co. Ltd, which is the top pharmaceutical company in Japan, and the plant manager of Tianjin Takeda Co. Ltd. in China.


The president Morimoto and his team have strong experiences on the new technology, such as TTS and DDS, and the technology transfer of external use medicine from Japan to China.


And he has more than 70 patents, including the technology for the formulation of cataplasms, the design and preparation of micro-sterile powder filling machine, tablet transfer system, high efficiency float granulating Coating machine, package and medical device, etc.


Morimoto-Pharma Group(MPG) is specialized in the research and development of new dosage forms especially for oral medication with the strength of high quality and advanced technology for manufacturing the new products.


MPG also covers the pharmaceutical field in the area of clinical trial, international trading, and Licensing business through Japan, China, Korean and USA with the subsidiary companies.


MPG aims to contribute to the developing and manufacturing of high valued medicinal products for human well being.


Our activities are independently conducted by each subsidiary company.



  • Manufacturing and selling M-Auger which is a Micro sterile powder filling machine, and Tab Screw which is the inline Screw Type of Tablet Transportation System changing your manufacturing line and plant with easy breakable objects like tablets, and could be very gently transported upwardly, downwardly and horizontally.
  • Consultation on formulation design and scale-up process.
  •   Trade of medical related material and machine.
  •   License, Business between 4 countries and R&D of new dosage form.
  • Representative of China CRO and Korea CRO.
  •   R & D of New Dosage Form and apply for drug company.


 (Tianjin) Morimoto (Tianjin) International Trade Co., Ltd.

  •   Trade of raw materials, machine, packaging materials.
  • Consulting service on Chinese current pharmaceuticals situation, including the policy, marketing investigation.
  •   Technical support for installation of  equipment and technical transfer.
  •   Coordinating China plant tour, support service for the exhibition, sy mposium and lecture (including preparing materials and translating)


(Beijing) China Morimoto Japan Pharma Co., Ltd.

  •   IND and DNA application to SFDA..
  • Support on Audit on the clinical trial in China, and also as an acting Auditor.
  •   Consultation on R&D in China, including the investigation on Medical organization and etc.
  • Consultation on marketing and promotion for those Japanese pharmaceuticals which are aimed to enter into Chinese market.


<Korea, Seoul>

  •   CRO           
  • CMO
  •   Licensing     
  •   Technical Transform
  • R&D




Add: 1-25 Matsugaoka Senriyama, Suita City, Osaka, Japan 565-0843

Mobile: +81-90-1242-7203 

Fax: +81-6-6380-8526   Url: http://www.morimoto-iyaku.jp; www.mijc.jp



Morimoto(Tianjin)International Trade Co.,Ltd
1-2406,JINGCAI Building,No.459, DaGu South Road,Hexi
District, Tianjin, China, PRC300202

TEL86-22-2326-0962 Fax: 86-22-2326-0963 http://www.morimoto.com.cn


Shanghai office

Room202,  NO.22 Caoyang Road, Putuo District, Shanghai, P.R.China. 200062
Tel: 86-21-3217-0881


China Morimoto Japan PHARMA CO., LTD.

2 Beijing City Chaoyang District left house Shonaka 号豪成大厦 1,505

Tel: 86-10-6569-6108


< Korea >

Mobile: +82-11-761-0018 Fax:+82-2-582-8952 

Add: Rm.#807,Seocho Hyundai Super Ville Office tel,

1466-11, Seocho-Dong, Seocho-Ku,Seoul,Korea



Morimoto Research Inc.

3545 Howord way, suite 220 Costa Mesa, CA 92626  Mobile: 82-10-5195-5374,

E-mail: kylee@mijc.jp